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Methods: A prospective study in 35 patients with variable forms of PMD or SPG2 was performed on a total of 66 cerebral MRI. A myelination score and a global atrophy score were determined for each MRI. We also performed image segmentation to calculate corpus callosum area, cerebellum, white matter and gray matter volumes.
Results: Multivariate analysis with adjustment to the age revealed a significant difference for global atrophy score and corpus callosum area in different subgroups of severity at the first MRI acquisition. Evolution of MRI over time showed an increasing score of myelination until the age of 12 years, followed by stabilization. On the contrary, global atrophy, atrophy of corpus callosum and cerebellum worsened in the majority of patients with aging. No change in gray matter and white matter proportions was noticed over time.
Discussion: This study points out a correlation between cerebral atrophy and clinical severity in patients with PMD and SPG2 whereas degree of myelination was not clearly discriminating. It also highlighted, for the first time in a large cohort of patients, a clear inter-and intra-individual cerebral atrophy over time involving white and gray matter. Moyamoya disease is a chronic, progressive occlusion of the circle of Willis arteries that leads to the development of characteristic collateral vessels seen on neuroimaging, particularly cerebral angiography.
The name "Moyamoya" means "puff of smoke" in Japanese and describes the look of the tangle of tiny vessels formed to compensate for the blockage. The incidence of Moyamoya disease is highest in Japan -0.35 cases per 100,000 people, and represents approximately 10 times more incidences than is found in Western countries. The highest peaks regarding the patients' age is first decade, and more often in female. At this time, Moyamoya disease is believed to be hereditary and the pathogenesis is unknown. The existing treatment options are controversial. This case report describes an 11-years-old Asian girl, who was diagnosed as having idiopathic Moyamoya disease, with a history of severe migraines and sleep disturbances, stroke-like event with balance, coordination, sensory and motor function impairment, together with three revascularisation surgeries. The patient had severe migraines attacks 3-4 times per week as a primary concern since she was 5 years old. She had problems with falling asleep as well as maintaining a full night's sleep; as a result, she developed mood and anxiety disordered features. Migraines and the functional abilities of the child showed significant improvement with a combination of surgical and conservative treatments. The patient is also a great example of taking a lead in her own responsibility in health and well-being by applying sleep hygiene recommendations and anxiety management with cognitive behaviour therapy. The sleep function improvement was seen on repeated polysomnographies studies from 1/2012 to 2/2014. A review of literature for the various facets of this condition is also provided. 
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